Taiyen Biotech Co Ltd Market Cap ($189.03 Million)
Market Cap & Net Worth: Taiyen Biotech Co Ltd (1737)
Taiyen Biotech Co Ltd market cap. Taiyen Biotech Co Ltd (TW:1737) has a market capitalization of $189.03 Million (NT$6.00 Billion) as of November 5, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #16566 globally and #804 in its home market, demonstrating a -0.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Taiyen Biotech Co Ltd's stock price NT$30.00 by its total outstanding shares 200000000 (200.00 Million). Also see Taiyen Biotech Co Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
Taiyen Biotech Co Ltd Market Cap History (2015–2026)
Taiyen Biotech Co Ltd market cap history from 2015 to 2026. Data shows growth from $143.50 Million to $189.03 Million (4.62% CAGR). Check Taiyen Biotech Co Ltd (1737) share price today for real-time trading data and today's change.
Taiyen Biotech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Taiyen Biotech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Taiyen Biotech Co Ltd (1737) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.06x
Taiyen Biotech Co Ltd's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.50x
Taiyen Biotech Co Ltd's market cap is 0.50 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $145.40 Million | $2.76 Billion | $351.97 Million | 0.05x | 0.41x |
| 2017 | $145.80 Million | $2.76 Billion | $353.69 Million | 0.05x | 0.41x |
| 2018 | $155.78 Million | $3.00 Billion | $452.74 Million | 0.05x | 0.34x |
| 2019 | $179.41 Million | $2.91 Billion | $345.50 Million | 0.06x | 0.52x |
| 2020 | $189.31 Million | $3.13 Billion | $365.08 Million | 0.06x | 0.52x |
| 2021 | $200.07 Million | $4.10 Billion | $393.23 Million | 0.05x | 0.51x |
| 2022 | $204.47 Million | $3.61 Billion | $426.70 Million | 0.06x | 0.48x |
| 2023 | $215.50 Million | $3.41 Billion | $300.39 Million | 0.06x | 0.72x |
| 2024 | $204.47 Million | $3.24 Billion | $371.52 Million | 0.06x | 0.55x |
| 2025 | $199.74 Million | $3.31 Billion | $399.87 Million | 0.06x | 0.50x |
Competitor Companies of 1737 by Market Capitalization
Companies near Taiyen Biotech Co Ltd in the global market cap rankings as of November 5, 2026. Also see total assets of Taiyen Biotech Co Ltd for a full breakdown of the balance sheet.
Key companies related to Taiyen Biotech Co Ltd by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #39 globally with a market cap of $373.42 Billion USD.
- LOREAL ADR 1/5/EO 02 (F:LORA): Ranked #98 globally with a market cap of $204.17 Billion USD ( €174.64 Billion EUR).
- LOréal S.A. (PA:OR): Ranked #99 globally with a market cap of $204.16 Billion USD ( €174.63 Billion EUR).
- Unilever PLC (NASDAQ:UNLYD): Ranked #200 globally with a market cap of $120.76 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #39 | Procter & Gamble Company | NYSE:PG | $373.42 Billion | $167.32 |
| #98 | LOREAL ADR 1/5/EO 02 | F:LORA | $204.17 Billion | €72.00 |
| #99 | LOréal S.A. | PA:OR | $204.16 Billion | €444.75 |
| #200 | Unilever PLC | NASDAQ:UNLYD | $120.76 Billion | $55.38 |
Market Capitalization of Taiyen Biotech Co Ltd (2015–2026)
Market capitalization of Taiyen Biotech Co Ltd from 2015 to today. Between 2015 and today, Taiyen Biotech Co Ltd's market cap moved from $143.50 Million to $ 189.03 Million, with a yearly change of 4.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$189.03 Million | -5.36% |
| 2025 | NT$199.74 Million | -2.31% |
| 2024 | NT$204.47 Million | -5.12% |
| 2023 | NT$215.50 Million | +5.39% |
| 2022 | NT$204.47 Million | +2.20% |
| 2021 | NT$200.07 Million | +5.69% |
| 2020 | NT$189.31 Million | +5.52% |
| 2019 | NT$179.41 Million | +15.17% |
| 2018 | NT$155.78 Million | +6.84% |
| 2017 | NT$145.80 Million | +0.28% |
| 2016 | NT$145.40 Million | +1.33% |
| 2015 | NT$143.50 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Taiyen Biotech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $189.03 Million USD |
| MoneyControl | $189.03 Million USD |
| MarketWatch | $189.03 Million USD |
| marketcap.company | $189.03 Million USD |
| Reuters | $189.03 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Taiyen Biotech Co Ltd
Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. It offers seawater chemicals; toothpaste, mouthwashes, and eyeglass solutions; beverages; bottled water; medical supplies; food and food additives; beauty, skincare, and cleaning products; and salt products; as well as health food and health products. The company was founded in 1952 and is … Read more